C51 -Malignant neoplasm of vulva
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C51 – N =5,996
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1982 | 32.9% | 21.4% | 22.9% | 8.6% | 14.3% | 140 |
1983 | 28.3% | 26.2% | 20.7% | 11.7% | 13.1% | 145 |
1984 | 27.1% | 21.5% | 25% | 9% | 17.4% | 144 |
1985 | 30.1% | 17.6% | 21.6% | 14.4% | 16.3% | 153 |
1986 | 29.6% | 22.2% | 23.5% | 14.8% | 9.9% | 162 |
1987 | 33.1% | 29.5% | 17.3% | 5% | 15.1% | 139 |
1988 | 23% | 20.3% | 23.6% | 10.1% | 23% | 148 |
1989 | 28.7% | 21% | 22.3% | 12.7% | 15.3% | 157 |
1990 | 31.2% | 18.1% | 26.8% | 10.1% | 13.8% | 138 |
1991 | 29.4% | 19.9% | 21.3% | 6.6% | 22.8% | 136 |
1992 | 26.7% | 22% | 21.3% | 10.7% | 19.3% | 150 |
1993 | 30.6% | 23.1% | 18.4% | 11.6% | 16.3% | 147 |
1994 | 34.2% | 20.5% | 22.4% | 4.3% | 18.6% | 161 |
1995 | 31.5% | 21.2% | 14.7% | 13.6% | 19% | 184 |
1996 | 37.6% | 16.2% | 14.5% | 10.4% | 21.4% | 173 |
1997 | 34.1% | 18.2% | 15.3% | 11.2% | 21.2% | 170 |
1998 | 31.3% | 17.9% | 17.9% | 12.9% | 19.9% | 201 |
1999 | 35.9% | 22.8% | 14.6% | 8.7% | 18% | 206 |
2000 | 32.5% | 25% | 16.5% | 9.9% | 16% | 212 |
2001 | 31.7% | 26.9% | 11.4% | 12% | 18% | 167 |
2002 | 32.8% | 19.6% | 20.6% | 9% | 18% | 189 |
2003 | 32.3% | 25% | 17.2% | 6.8% | 18.8% | 192 |
2004 | 36% | 20.7% | 17.2% | 6.4% | 19.7% | 203 |
2005 | 31.3% | 12.4% | 18.9% | 12.4% | 24.9% | 217 |
2006 | 43.1% | 21.3% | 21.8% | 8.1% | 5.6% | 197 |
2007 | 32.8% | 27.6% | 20.8% | 10.9% | 7.8% | 192 |
2008 | 35.5% | 23.2% | 15.3% | 18.2% | 7.9% | 203 |
2009 | 43% | 22% | 19% | 9.5% | 6.5% | 200 |
2010 | 41.8% | 18.2% | 19.1% | 16% | 4.9% | 225 |
2011 | 48.4% | 11.9% | 10.5% | 14.2% | 15.1% | 219 |
2012 | 51.5% | 8.2% | 8.6% | 11.2% | 20.6% | 233 |
2013 | 50.7% | 8.9% | 10.4% | 11.9% | 18.1% | 270 |
2014 | 58.7% | 9.4% | 12.6% | 10.8% | 8.5% | 223 |